Recursion Pharmaceuticals Inc (RXRX) — Net Asset Quality Index
Recursion Pharmaceuticals Inc (RXRX) has a Net Asset Quality Index of 76.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.34 Billion minus total liabilities of $314.75 Million yields net assets of $1.02 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Recursion Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Recursion Pharmaceuticals Inc Net Asset Quality Index Over Time (2019–2025)
This chart shows how Recursion Pharmaceuticals Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 76.5%, representing net assets of $1.02 Billion against total assets of $1.34 Billion USD. See RXRX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Recursion Pharmaceuticals Inc (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Recursion Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RXRX market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.7% | $1.13 Billion | $1.47 Billion | $343.26 Million | ▲ +5.3 pp |
| 2024 | 71.4% | $1.03 Billion | $1.45 Billion | $413.82 Million | ▲ +0.5 pp |
| 2023 | 70.9% | $463.44 Million | $653.70 Million | $190.26 Million | ▲ +1.6 pp |
| 2022 | 69.3% | $485.81 Million | $701.29 Million | $215.48 Million | ▼ -19.7 pp |
| 2021 | 89.0% | $542.94 Million | $610.35 Million | $67.41 Million | ▲ +158.0 pp |
| 2020 | -69.1% | $-206.29 Million | $298.58 Million | $504.87 Million | ▲ +53.4 pp |
| 2019 | -122.5% | $-124.27 Million | $101.43 Million | $225.70 Million | — |